Clinical Trial: Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Prospective, Open Label Trial of High Dose UVA-1, 3x/Week or Medium Dose UVA-1, 3x/Week vs. Fluocinonide 0.05% Cream Treatment of Morphea
Brief Summary: Compare UVA-1 phototherapy treatment to topical steroid treatment in subjects with morphea.
Detailed Summary:
Sponsor: University of Texas Southwestern Medical Center
Current Primary Outcome: Efficacy of UVA-1 treatment vs. topical steroid. [ Time Frame: 5 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: University of Texas Southwestern Medical Center
Dates:
Date Received: December 18, 2008
Date Started: November 2004
Date Completion:
Last Updated: December 8, 2014
Last Verified: December 2014